Embrace performance for detection
Assays

Embrace performance for detection of Clostridioides difficile infection (CDI)*

BD MAX™ Cdiff assay designed for diagnostic speed and accuracy

The BD MAXTM Cdiff assay provides rapid detection of the C. difficile toxin B gene (tcdB),
the gene essential for CDI1, including infections caused by hypervirulent strains

  • CDI is the most important (preventable) infective cause of healthcare-associated diarrhoea in Europe and is associated with high morbidity and mortality3
  • The BD MAX™ Cdiff assay is a real time polymerase chain reaction (PCR) assay offering diagnostic speed and accuracy to allow fast treatment decisions and prevent transmission of infection2
  • Traditional diagnostic methods can be time-consuming (toxigenic culture or cell cytotoxicity neutralization assay) or may have poor sensitivity (glutamate dehydrogenase assays)4-5
  • PCR is recommended by ESCMID guidelines as a primary test in a 2-step algorithm for diagnosis of CDI3
  • The BD MAX™ Cdiff assay is integrated on the fully automated BD MAX™ System and is run compatible with
    other healthcare associated infection (HAI) assays2
  • Results are available in approximately 2 hours with only 1 minute of hands-on time per specimen2
Improved patient <br />
management
Improved patient
management
Workflow<br />
efficiency
Workflow
efficiency
Diagnostic<br />
accuracy
Diagnostic
accuracy

Characteristics of the BD MAX™ Cdiff assay


TestSample type2Storage and Stability2Target
BD MAX™ Cdiff
  • Unpreserved stool
  • Specimens can be stored for up to 120 hours (5 days) at 2–8°C or for up to 48 hours at 2–25°C before testing
  • Transport should occur at 2–25°C
  • Clostridioides difficile* toxin B gene (tcdB)
TestBD MAX™ Cdiff
Sample type2
  • Unpreserved stool
Storage and Stability2
  • Specimens can be stored for up to 120 hours (5 days) at 2–8°C or for up to 48 hours at 2–25°C before testing
  • Transport should occur at 2–25°C
Target
  • Clostridioides difficile* toxin B gene (tcdB)

BD MAX™ Cdiffis part of the BD MAX™ Portfolio of HAI Assays